Mrv1652306131722022D 18 19 0 0 1 0 999 V2000 0.1067 4.7652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6078 4.3527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6078 3.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 3.1152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.0367 3.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7512 3.1152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.0367 4.3527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 4.7652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 5.5902 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 2.2902 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.6548 1.8053 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.9097 1.0206 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.7347 1.0206 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.9897 1.8053 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.2197 0.3532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8841 -0.4005 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.4248 0.3532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.1298 2.0602 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 2 0 0 0 0 5 7 1 0 0 0 0 7 8 1 0 0 0 0 2 8 1 0 0 0 0 8 9 2 0 0 0 0 10 4 1 6 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 10 14 1 0 0 0 0 13 15 1 6 0 0 0 15 16 1 0 0 0 0 12 17 1 1 0 0 0 11 18 1 6 0 0 0 M END > DB06683 > drugbank > CC1=CN([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)C(=O)NC1=O > InChI=1S/C10H13FN2O5/c1-4-2-13(10(17)12-8(4)16)9-6(11)7(15)5(3-14)18-9/h2,5-7,9,14-15H,3H2,1H3,(H,12,16,17)/t5-,6+,7-,9-/m0/s1 > GBBJCSTXCAQSSJ-XQXXSGGOSA-N > C10H13FN2O5 > 260.221 > 260.08084969 > 5 > 31 > 23.200590855129636 > 1 > 3 > 0 > 0 > 1-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione > -0.72 > -1.1285998783333329 > -0.47 > 0 > 2 > 0 > 12.736995396828615 > 10.104350675704374 > -2.9805440359948054 > 99.10000000000001 > 55.23060000000001 > 2 > 1 > 8.77e+01 g/l > 1-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-3H-pyrimidine-2,4-dione > 0 > DB06683 > investigational > Clevudine > 2'-Fluoro-5-methyl-beta-L-arabinofuranosyluracil; Clevudine; L-FMAU $$$$